Research
Hormonal
Semaglutide has a favorable safety profile across diverse patient populations and treatment durations.
Clinicians can consider semaglutide as a safe option for managing type 2 diabetes and obesity.
StrongSupportsmedium confidence
Semaglutide appears to have a favorable safety profile across diverse patient populations and treatment durations.
Why this rating
Based on the meta-analysis of 23 studies with a large sample size.
Source
Evaluating the safety profile of semaglutide: an updated meta-analysis
Frederick Berro Rivera et al. · Current Medical Research and Opinion · 2024
Meta-analysisCited 10×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →